Filing Details

Accession Number:
0001127602-23-001969
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-20 17:21:45
Reporting Period:
2023-01-19
Accepted Time:
2023-01-20 17:21:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1830214 Ginkgo Bioworks Holdings Inc. DNA Biological Products, (No Disgnostic Substances) (2836) 872652913
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1882756 Barry Canton C/O Ginkgo Bioworks Holdings
27 Drydock Avenue
Boston MA 02210
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2023-01-19 37,650 $1.69 16,305,050 No 4 S Direct
Class A Common Stock Disposition 2023-01-19 162,193 $1.71 16,142,857 No 4 S Direct
Class A Common Stock Disposition 2023-01-19 162,193 $1.71 16,142,867 No 4 S Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Indirect By Spouse
Footnotes
  1. The shares were sold pursuant to a sales plan adopted by the Reporting Person or the Reporting Person's spouse and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.64 to $1.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  3. Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.